Levacetylleucine (Aqneursa) improved functioning in a phase III crossover trial of adults and children with ataxia-telangiectasia. Two patients had three treatment-emergent adverse events; none were ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Morning Overview on MSN
A new pancreatic-cancer drug nearly doubled survival and cut the risk of death by 60%
Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared ...
HOUSTON, JULY 2, 2026 ― A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
A viral YouTube video completely shatters expectations about what modern software can do in the garage. The footage documents ...
Does the type of primary angle-closure glaucoma (PACG) a patient has influence how well they respond to combined cataract and ...
Looking for a great game to play on your Switch or Switch 2? Check out Hades II, Mina the Hollower, Monster Hunter Rise, and ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results